The Bleeding Jehovah s Witness: A Nightmare Scenario?

Similar documents
Blood Conservation. To introduce the learner to the basic concepts of blood conservation!! Learning Outcomes

Non-Medical Authorisation Course TRANSFUSION ALTERNATIVES. East Midlands Regional Transfusion Committee

Transfusion Requirements and Management in Trauma RACHEL JACK

Patient Blood Management. vs. Dr. Petro-Lize Wessels PBM Consultant SANBS August 2018

A Guide To Safe Blood Transfusion Practice

British Society of Gastroenterology. St. Elsewhere's Hospital. National Comparative Audit of Blood Transfusion

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.

OSPITAL IAISON OMMITTEE

Clinical guideline Published: 13 June 2012 nice.org.uk/guidance/cg141

ORBcoN Spring Symposium April 2015

Transfusion Triggers. Richard Soutar January 2012

Major Haemorrhage Protocol. Commentary

The principle of 1:1:1 blood product use in the resuscitation of trauma victims. K. D. Boffard

MANAGEMENT OF COAGULOPATHY AFTER TRAUMA OR MAJOR SURGERY

Laboratory Empowerment. Debbie Asher Adrian Ebbs Transfusion Laboratory Managers, Eastern Pathology Alliance

Blood Transfusion Guidelines in Clinical Practice

Bleeding, Coagulopathy, and Thrombosis in the Injured Patient

Massive transfusion: Recent advances, guidelines & strategies. Dr.A.Surekha Devi Head, Dept. of Transfusion Medicine Global Hospital Hyderabad

Patient Blood Management. Marisa B. Marques, MD UAB Department of Pathology November 17, 2016

Intraoperative haemorrhage and haemostasis. Dr. med. Christian Quadri Capoclinica Anestesia, ORL

Coagulation, Haemostasis and interpretation of Coagulation tests

My Bloody Talk. Dr Ben Turner MBBS, FANZCA, FCICM The Royal Children s Hospital, Melbourne

GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS

Anaemia in the ICU: Is there an alternative to using blood transfusion?

Heme (Bleeding and Coagulopathies) in the ICU

Major Haemorrhage Transfusion Pathway

TRANSFUSION GUIDELINES FOR CARDIOTHORACIC UNIT 2006

John Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne

Blood Management and Protocol Use in Active Bleeding

Patient Blood Management and alternatives to transfusion

Administration of blood components. Tina Parker - Transfusion Practitioner

Massive Transfusion. MPQC Spring Summit April 29, Roger Belizaire MD PhD

Blood Product Utilization A Mythbusters! Style Review. Amanda Haynes, DO 4/28/18

NICE guideline Published: 18 November 2015 nice.org.uk/guidance/ng24

Document for Obstetric Patients Who Refuse Consent for Blood and Blood Product Administration, Including Jehovah s Witnesses

Blood is serious business

Crossmatching and Issuing Blood Components; Indications and Effects.

Managing Coagulopathy in Intensive Care Setting

ERYTHROPOIETIC STIMULATING AGENTS IN THE ICU: A MOVING PUZZLE

Patient Blood Management: Enough is Enough

Chapter 3 MAKING THE DECISION TO TRANSFUSE

Patient Blood Management: Exploring the Options. Perioperative Blood Management Services November 4, 2011

Approach to disseminated intravascular coagulation

Patient Blood Management in the Netherlands: Between practice and evidence

Gastro-Intestinal Bleeding- Interventional Radiology turning off the tap. Simon McPherson, Vascular Interventional Radiologist, Leeds

Advances in Transfusion and Blood Conservation

Patient Blood Management Are you providing this? Jeannie Callum, BA, MD, FRCPC Associate Professor, University of Toronto

WELCOME. Evaluation Summary

GUIDELINES FOR MANAGEMENT OF BLEEDING AND EXCESSIVE ANTICOAGULATION WITH ORAL ANTICOAGULANTS

Preparing for Patients at High Risk of Transfusion

Haematology and Transfusion

The research questions are presented in priority order, and are further elaborated with lay summaries and three-part questions where applicable.

Patient blood management and perioperative anaemia

The Concept of Patient Blood Management Daniela Filipescu, MD, PhD, DEAA

Haematology and Transfusion

Bloodless Medicine and Surgery Program. The Only Bloodless Medicine and Surgery Program in the D.C. Area

Guidance for management of bleeding in patients taking the new oral anticoagulant drugs: rivaroxaban, dabigatran or apixaban

Effective Date: Approved by: Laboratory Director, Jerry Barker (electronic signature)

Risk assessment in UGIB: recent PCI & ACS. Dr Martin James PhD FRCP October 20 th 2016 Nottingham Endoscopy Masterclass

Damage Control Resuscitation. VGH Trauma Rounds 2018 Harvey Hawes

A Patient s guide to. Blood Transfusions and Human Tissue Transplant

Blood Transfusions in Children with Haemoglobinopathies

Transfusions in Acute Care Too Little?

and Securing the Blood Supply Under Clinical Transfusion Governance

Dr Marina Karakantza Consultant Haematologist, NHSBT

Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document"

A Patient s guide to. Blood Transfusions and Human Tissue Transplant

the bleeding won t stop? Liane Manz RN, BScN, CNCC(c) Royal Alexandra Hospital

Unrestricted. Dr ppooransari fellowship of perenatalogy

Pre-operative Anaemia Colorectal and Orthopaedic Surgery

How can ROTEM testing help you in trauma?

Oral anticoagulant agent-associated bleeding events reporting system (ORANGE study)

2/2/2011. Blood Components and Transfusions. Why Blood Transfusion?

YEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY

Clinical and Cost Effectiveness of Darbepoetin alfa in Cancer Treatment-induced Anaemia

Sign up to receive ATOTW weekly

Blood and blood component therapy in the critically ill patient

PBM: The Future of Transfusion December 6 th 2012 East of England RTC. Sue Mallett Royal Free London NHS Foundation Trust

Dr Shikha Chattree Haematology Consultant Sunderland Royal infirmary

Management of Challenging Bleeding: Patients with Coagulopathy

Thrombocytopenia and Chronic Liver Disease

TRANSFUSION SUPPORT IN HEPATOBILIARY AND PANCREATIC SURGERIES

EMSS17: Bleeding patients course material

Approach to bleeding disorders &treatment. by RAJESH.N General medicine post graduate

Use of Prothrombin Complex Concentrate to Reverse Coagulopathy Rio Grande Trauma Conference

When should I transfuse platelets and plasma for children? Dr Liz Chalmers. Consultant Paediatric Haematologist Royal Hospital for Children Glasgow

Anaemia & Cancer. John de Vos Consultant Haematologist RSCH

Cancer associated thrombosis palliative care and the end of life. Tracy Anderson May 2017

MASSIVE TRANSFUSION DR.K.HITESH KUMAR FINAL YEAR PG DEPT. OF TRANSFUSION MEDICINE

STATUS OF EARLY MORTALITY IN NEWLY DIAGNOSED CASES OF ACUTE PROMYELOCYTIC LEUKAEMIA (APL) IN BSMMU HOSPITAL

Third Pillar. Tolerance of Anaemia

Patient Blood Management. Peter Freeman Patient Blood Management Officer Clinical Operations Hunter New England LHD.

Components of Blood. N26 Blood Administration 4/24/2012. Cabrillo College ADN/C. Madsen RN, MSN 1. Formed elements Cells. Plasma. What can we give?

Guideline for the Management of Upper Gastrointestinal Bleeding in Children

Survey of Massive Blood Loss In the North East of England 2013

Early Management of the Patient with Acute GI Bleeding

Transfusion 2004: Current Practice Standards. Kay Elliott, MT (ASCP) SBB SWMC Transfusion Service

Iron Deficiency Anaemia but Why? Dr LAU Ching-wa Specialist in Haematology Blood Transfusion Service

Chest diseases Hospital Laboratory Hematology Practice guidelines

Transfusion Pitfalls. Objectives. Packed Red Blood Cells. TRICC trial (subgroups): Is transfusion always good? Components

Transcription:

The Bleeding Jehovah s Witness: A Nightmare Scenario? David Smith, Bristol Hospital Liaison Committee for Jehovah s Witnesses SW RTC: Bleeding in the Medical Patient - 21 February 2018

Jehovah s Witnesses ~ Putting them in context Circa 1:300 of your patients

Why Witnesses decline blood The Scriptures (Acts 15): Abstain from... blood... If you keep free from these things you will be doing right. RCS Caring for Patients who Refuse Blood (2016): JWs appreciate high-quality care. They value life and want to do whatever is reasonable and compatible with their beliefs to prolong it.

NO 1. Whole Blood 2.RBCs 3. Platelets 4. Plasma (FFP, Octaplas, Lyoplas) 5. WBCs 6. PAD Check 1. Autologous procedures eg Cell Salvage 2. Fractions eg Fibrinogen and other factor concentrates, Albumin, PCC, Cryoprecipitate 3. Transplants No other limitations. Key modalities include: Antifibrinolytics Meticulous Haemostasis Oral & IV Iron Non-blood haemostats, eg Celox Minimal sampling ESAs YES Recombinants

Communicating Choices: Key Documents & Wristband 3/19/2018

460 and 461 patients in the two groups Hb levels at admission: 95g/L No Transfusion 6 week survival Re Bleeding Adverse Events 45 day Mortality 90g/L trigger 15% 91% 16% 48% 9% 70g/L trigger 51% 95% 10% 40% 5%

OVERVIEW FOR THE BLEEDING JW MEDICAL PATIENT No unique procedures or medications so speed and a multimodal approach are crucial 1. Address anaemia even if moderate 2. Identify source of bleeding 3. Treat bleeding & clotting disorders 4. Lower than normal threshold for surgery 1. IV Vit K for severe bleeding 2. Prompt TXA 3. Early or pre-emptive ESAs & iron 4. All surgical & anaesthetic techniques 5. Interventional radiology

How to proceed: UGIB Care Pathway at UHB 3/19/2018

JW with Severe Anaemia: Hb < 70g/L Initiate Anaemia Protocol: EPO: 40k units daily until Hb > 70 g/l, then 40k units weekly. Iron: 100mg IV iron daily for10 days minimum and then consider conversion to oral. Vitamin C, Folate & Vitamin B12 For multiple scenarios including burn injury, GI haemorrhage, trauma, chemotherapy and THA: A multimodal approach is required. enhance endogenous erythropoiesis, reduce blood loss, increase oxygen delivery and reduce oxygen consumption, and avoid hemodilution and iatrogenic anemia. Monitor Hb etc daily with blood gas (0.3ml) Control bleeding; correct coagulopathy Reduce oxygen consumption Supplemental oxygen Avoid haemodilution How do we treat life-threatening anemia in a Jehovah s Witness patient? Posluszny and Napolitano Transfusion 2014;54:3026-34

OPERATIVE TECHNIQUES TO MINIMISE BLOOD LOSS Caring for Patients who Refuse Blood, RCS 2016 Techniques to minimize blood loss Anaesthetic Autologous Coagulation stimulants Haemostatic aids Laparoscopic instead of open surgery; interventional radiology; staged procedures; vasoconstrictors, tourniquet & clamps to stem blood flow Controlled hypotension; regional anaesthesia Cell salvage*; ANH* Tranexamic Acid; Recombinant clotting factors VIIa*, VIII, IX; Desmopressin Diathermy; harmonic scalpels; radiofrequency ablation

GI Bleed Treatment Options INTRAVENOUS IRON: TATM 12 (2012) 122-9 INTERVENTIONAL RADIOLOGY: WJ RADIOL 6 (2014) 4:82 Interventional radiology becomes vital in patients whose GIB remains resistant to medical and endoscopic treatment. Radiology offers diagnostic imaging studies and endovascular therapeutic interventions that can be performed promptly and effectively with successful outcomes.

Acute upper gastrointestinal bleeding in over 16s NICE Clinical guideline [CG141] Published date: June 2012 Last updated: August 2016 o (Introduction) Acute upper gastrointestinal bleeding has a 10% hospital mortality rate. Elderly patients and people with chronic medical diseases have a higher risk of death. o 1.2.2 Base decisions on blood transfusion on the full clinical picture, recognising that over-transfusion may be as damaging as under-transfusion. o 1.2.7 Do not use factor Vlla except when all other methods have failed. o 1.4.7 (Key Priority) Offer interventional radiology to unstable patients who re-bleed after endoscopic treatment. o 1.5.5 Offer endoscopic injection of N-butyl-2-cyanoacrylate to patients with UGI bleeding from gastric varices.

Intensive Care Recommendations from Caring for Patients who Refuse Blood, RCS 2016 [E3] 1. Monitor and minimise postop blood loss 2. Monitor and avoid sepsis. 3. Minimise number/volume of blood samples (can be >70ml/day in ICU AJCC, 2013) 4. Ensure staff are aware of the refusal of blood to ensure extra monitoring. 5. Consider postoperative EPO and/or Iron/B12. 6. Consider postop blood salvage from drains.

Multi-Modal Management: Hepatic Bleed in 75 year old o 2am admission to A&E with major bleed from hepatic artery - Hb 55g/L. o TXA, Darbepoetin & IV Iron administered per Trust Policy for JWs. o Open repair would likely have increased blood loss and risk of mortality hence case referred for interventional radiology o TAE (Transcatheter Arterial Embolization) carried out at 7am bleeding arrested o 2pm: No hepatic artery bleeding: Hb > 70g/L o Patient discharged day 3 with Hb > 100g/L

o More open to having earlier discussions to allow our patients a better say and understanding about their end-of-life wishes o The majority of doctors would not like their lives prolonged if the likely risks and burdens of treatment would outweigh the expected benefits. 3/19/2018

How Far for JWs?? We do not believe that extraordinary, complicated, distressing or costly measures must be taken to sustain a dying person. The consensus may be that those measures would merely prolong the dying process and/or leave the patient with no meaningful life. JWs: Our Views on Healthcare, 2017

In Conclusion: What s Different for Jehovah s Witnesses? o No Blood = firm expectation not simply nice if possible. o Prompt & clear identification of what is acceptable for each patient is vital and must be communicated at handovers. o Clinical toolkit is almost always standard PBM, but often will need to be applied earlier, more aggressively and with multidisciplinary input. o Impact is attritional. o Witnesses (have) driven many workers to find alternative strategies for avoiding bleeding and treating it. These have proved successful, and are now not limited to Jehovah s Witnesses, for which wider society owes them a debt of gratitude. Prof Martin Elliott, GOSH; Gresham lecture 2017

And finally. 3/19/2018